AR117298A1 - PEPTIDE BINDER - Google Patents

PEPTIDE BINDER

Info

Publication number
AR117298A1
AR117298A1 ARP190103608A ARP190103608A AR117298A1 AR 117298 A1 AR117298 A1 AR 117298A1 AR P190103608 A ARP190103608 A AR P190103608A AR P190103608 A ARP190103608 A AR P190103608A AR 117298 A1 AR117298 A1 AR 117298A1
Authority
AR
Argentina
Prior art keywords
sulfonamide
conjugate
formula
peptide binder
active ingredient
Prior art date
Application number
ARP190103608A
Other languages
Spanish (es)
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of AR117298A1 publication Critical patent/AR117298A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins

Abstract

La presente se refiere a una sulfonamida de la fórmula (2); un conjugado que comprende una sulfonamida de la fórmula (1) y un ingrediente farmacéuticamente activo; un proceso de preparación de un conjugado que comprende una sulfonamida de la fórmula (1) y un ingrediente farmacéuticamente activo; una composición farmacéutica que comprende el conjugado que comprende una sulfonamida de la fórmula (1) y un ingrediente farmacéuticamente activo; y al uso del conjugado como un medicamento.This refers to a sulfonamide of the formula (2); a conjugate comprising a sulfonamide of the formula (1) and a pharmaceutically active ingredient; a process for preparing a conjugate comprising a sulfonamide of the formula (1) and a pharmaceutically active ingredient; a pharmaceutical composition comprising the conjugate comprising a sulfonamide of the formula (1) and a pharmaceutically active ingredient; and to the use of the conjugate as a medicine.

ARP190103608A 2018-12-11 2019-12-11 PEPTIDE BINDER AR117298A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18306657 2018-12-11

Publications (1)

Publication Number Publication Date
AR117298A1 true AR117298A1 (en) 2021-07-28

Family

ID=65279373

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP190103608A AR117298A1 (en) 2018-12-11 2019-12-11 PEPTIDE BINDER
ARP190103610A AR117300A1 (en) 2018-12-11 2019-12-11 INSULIN ANALOGUES WITH REDUCED INSULIN RECEPTOR BINDING AFFINITY
ARP190103609A AR117299A1 (en) 2018-12-11 2019-12-11 INSULIN CONJUGATES

Family Applications After (2)

Application Number Title Priority Date Filing Date
ARP190103610A AR117300A1 (en) 2018-12-11 2019-12-11 INSULIN ANALOGUES WITH REDUCED INSULIN RECEPTOR BINDING AFFINITY
ARP190103609A AR117299A1 (en) 2018-12-11 2019-12-11 INSULIN CONJUGATES

Country Status (1)

Country Link
AR (3) AR117298A1 (en)

Also Published As

Publication number Publication date
AR117300A1 (en) 2021-07-28
AR117299A1 (en) 2021-07-28

Similar Documents

Publication Publication Date Title
DOP2022000124A (en) PYRAZOLIL DERIVATIVES USEFUL AS ANTICANCER AGENTS
CY1119490T1 (en) PYRAZOLOPYROLIDINE PRODUCTS AND THEIR USE IN PATIENT TREATMENT
CL2017000379A1 (en) Pyrrolopyrimidine compounds used as toll receptor agonists. 7 (tlr7)
UY36465A (en) CARBAMOILPIRIDONE POLICYCLY COMPOUNDS AND THEIR PHARMACEUTICAL USE
CR20170563A (en) BENZOXACEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE.
UY37741A (en) INDOLINA DERIVATIVES REPLACED AS INHIBITORS OF THE DENGUE VIRUS REPLICATION
CU20150096A7 (en) AMIDA COMPOUNDS AND PHARMACEUTICAL COMPOSITION FOR HIV TREATMENT
PE20151437A1 (en) SPIRO-LACTAMA NMDA RECEIVER MODULATORS AND THEIR USES
MX2021006969A (en) Peptide binder.
GT200600445A (en) SOLID PHARMACEUTICAL PRESENTATION FORMS OF ORAL ADMINISTRATION WITH QUICK RELEASE OF THE ACTIVE PRINCIPLE.
AR104984A1 (en) SELECTIVE COMPOUNDS FOR PYY AND ITS USES
DOP2011000343A (en) PIRIDINE TIENO DERIVATIVES [2,3-B] AS VIRAL REPLICATION INHIBITORS
NZ735575A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
EA201491479A1 (en) DERIVATIVES OF LUPANOV TRITERPENOIDS AND THEIR PHARMACEUTICAL APPLICATIONS
BR112015018087A8 (en) compound, pharmaceutical composition and use
CO2019000945A2 (en) Modulators of the nmda spiro-lactam receptor and use thereof
CO2019000943A2 (en) Modulators of the nmda spiro-lactam receptor and use thereof
AR101674A1 (en) USE OF A TRICYCLIC COMPOUND CONTAINING NITROGEN
UY38228A (en) TRIAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
DOP2019000100A (en) DERIVATIVES OF NAFTIRIDINONE AND ITS USE IN THE TREATMENT OF ARRITMIA
PE20151607A1 (en) ORGANIC COMPOUND FORMULATIONS
CL2022000893A1 (en) 2-Azaspiro[3,4]octane derivatives as m4 agonists
AR114418A1 (en) CYCLIC COMPOUND OF METHYLACTAM AND ITS PHARMACEUTICAL USE
SV2011003896A (en) PIRROLIDINS